Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
Not Applicable
Completed
- Conditions
- Respiratory Tract Diseases
- Interventions
- Other: Petroleum jellyOther: Ointment containing camphor, eucalyptus oil, and menthol
- Registration Number
- NCT00743990
- Lead Sponsor
- Penn State University
- Brief Summary
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 143
Inclusion Criteria
- Cough and congestion attributed to upper respiratory tract infection
Exclusion Criteria
- Children with signs or symptoms of more serious or treatable disease
- Presence of itchy, watery eyes or frequent sneezing
- Tachypnea (respiratory rate >95%ile) or labored breathing
- Symptoms for 8 or more days
- History of asthma in the past 2 years, chronic lung disease, or seizure disorder
- History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Over-the-counter medication containing VVR components
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description B Petroleum jelly - A Ointment containing camphor, eucalyptus oil, and menthol -
- Primary Outcome Measures
Name Time Method Subjective assessment of cough and congestion symptoms 24 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Penn State Milton S. Hershey Medical Center
🇺🇸Hershey, Pennsylvania, United States